AURO-PAZOPANIB
AURO PHARMA INC
Quick answers
Is there a shortage of AURO-PAZOPANIB in Canada?
No. There is no current shortage of AURO-PAZOPANIB 200MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-PAZOPANIB
PHARMASCIENCE INC
SANDOZ PAZOPANIB
SANDOZ CANADA INCORPORATED
Other Products
VOTRIENT
NOVARTIS PHARMACEUTICALS CANADA INC
DIN
02552957
Strength
200MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
PAZOPANIB (PAZOPANIB HYDROCHLORIDE)
See all PAZOPANIB (PAZOPANIB HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from AURO PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02494558
2G · DIN 02462346
500MG · DIN 02462311
1G · DIN 02462338
250MG · DIN 02462303
DIN 02454513
70MG · DIN 02388553
10MG · DIN 02388545
10MG · DIN 02443201
10MG · DIN 02397080
5MG · DIN 02397072
250MG · DIN 02458594